Oncology Voice Network
Join to access to all OVN content. Join for Free
MSL Field Sanity: Top 10 Tips for Field Survival
Medical Science Liaison health tips MSL travel strategies healthy eating for MSLs improving sleep quality for MSLs work-life balance for Medical Science Liaisons.

MSL Field Sanity: Top 10 Tips for Field Survival

  • Apr 27th 2021
  • 43 mins
  • E52

Share This Article

Summary

In this episode, Maria Urso joins Tom Caravela to delve into the challenges and strategies for maintaining health as a traveling Medical Science Liaison (MSL). They explore practical advice for healthy eating on the road, managing alcohol intake, and staying hydrated. The conversation highlights the importance of staying active and offers tips for incorporating exercise into a busy travel schedule. Maria and Tom also discuss improving sleep quality using meditation apps and finding a balance between work and personal life. The episode emphasizes the power of consistent small improvements and concludes with expressions of gratitude.

Maria Urso, Director, Medical Affairs Field Team at Exact Sciences discusses MSL Field Sanity: Top 10 Tips for Field Survival

Maria discusses the importance of:

 Nutrition
 Hydration
 Sleep (and how to get it)
 Exercise
 And a whole lot more

Click for Source
Medical Science Liaison health tips, MSL travel strategies, healthy eating for MSLs, improving sleep quality for MSLs, work-life balance for Medical Science Liaisons.

Related Topics

Explore the Ecosystem

Meet Our Innovation Partners

You May Also Like

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Apr 8th • 4 mins • read
Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Apr 7th • 12 mins • read
Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

May 6th • 18 mins • read
Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16th • 5 mins • read
Article
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Partner Avatar iNIZIO

Virtual Oncology MSL Team Increases KOL Engagement by 120%

Sep 3rd • 1 min • read
Article
Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis
OVN Avatar Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Feb 23rd • 8 mins • read

Explore OVN

Articles Expert-written insights
Browse Topics Oncology focus areas
OVN Podcast Flagship show
Community Why join OVN